Shakhtar Donetsk Faces €30 Million Deficit as Mudryk Doping Suspension Freezes Performance Bonuses

Shakhtar CEO Serhii Palkin warns of a €30M financial hit as Mykhailo Mudryk’s doping suspension blocks Chelsea bonus payments. Read the full update.

By: AXL Media

Published: Apr 29, 2026, 8:12 AM EDT

Source: Information for this report was sourced from YSScores

The Financial Aftershocks of a Disputed Sample

The record-breaking transfer of Mykhailo Mudryk from Shakhtar Donetsk to Chelsea has transitioned from a sporting triumph into a protracted financial crisis for the Ukrainian club. On April 29, 2026, reports clarified that the London club’s obligation to pay performance-based bonuses has been effectively frozen due to Mudryk’s prolonged absence from competitive play. The winger has been unavailable since November 2024, following an "adverse finding" for the banned substance meldonium in a sample collected during his international duties with Ukraine. This medical impasse has now translated into a direct threat to Shakhtar’s budgetary stability.

A €30 Million Incentive Package at Risk

When Mudryk moved to Stamford Bridge in January 2023, the deal was structured with a €70 million base fee and an additional €30 million in incentives. These bonuses were contingent on specific milestones, including match appearances and Chelsea’s qualification for elite European competitions. However, with Mudryk stripped of his squad number and approaching 18 months without a professional minute, these triggers have become unreachable. Shakhtar CEO Serhii Palkin emphasized that the loss of this income represents a "strong financial blow," as the club had integrated these projected revenues into their long-term operational planning.

The Shadow of a Four-Year Global Ban

The legal proceedings surrounding the 25-year-old winger have entered a critical phase as the Football Association (FA) and international anti-doping authorities deliberate on a final sanction. Mudryk was formally charged in June 2025 after his B-sample confirmed the presence of meldonium, a substance typically used to increase blood flow and endurance. While the player has maintained his innocence, asserting that he "never knowingly" ingested any prohibited substances, he remains at risk of a maximum four-year suspension. Such a verdict would likely void the remaining years of his Chelsea contract and permanently terminate Shakhtar’s claim to the outstanding bonus payments.